PTGDR2 and alopecia: In other tissues, the action of endogenous prostaglandin D2 (PGD2) on GPR44 in hair follicles has been linked to hair loss alopecia [21, 22], triggering research into a potential role of GPR44 antagonists as treatment for baldness [23].